Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Urokinase Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Industry: Pharma & Healthcare
Published Date: 2024-04-17
Pages: 142 Pages
Report ld: 2695707
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Urokinase Market Size(US$)
CAGR 2024-2030
5.2%
Market Size,2030
USD 64
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 48 million
Market Forecast in 2030(Value)
US$ 64 million
CAGR
5.2%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
The global Urokinase market size was US$ 45 million in 2023 and is forecast to a readjusted size of US$ 64 million by 2030 with a CAGR of 5.2% during the forecast period 2024-2030.
Global key players of urokinase include Syner-Med, LIVZON, Wanhua Biochem, etc. The top three players hold a share about 50%. China is the largest market of Urokinase, holding a share about 56%, followed by Europe and North America.
In terms of sales (consumption) side, this report focuses on the sales of Urokinase by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Urokinase market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Urokinase market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
By Company
- Syner-Med
- Wanhua Biochem
- Jiangxi Haoran Bio-Pharma
- Jiangsu Aidea Pharmaceutical
- Techpool
- Microbic Biosystems
- LIVZON
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Urokinase Powder
- Urokinase Solution
Segment by Application
- Hospital
- Clinic
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Urokinase in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Urokinase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urokinase sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Urokinase Definition
1.2 Market by Type
1.2.1 Global Urokinase Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Urokinase Powder
1.2.3 Urokinase Solution
1.3 Market Segment by Application
1.3.1 Global Urokinase Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Urokinase Sales
2.1 Global Urokinase Revenue Estimates and Forecasts 2019-2030
2.2 Global Urokinase Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Urokinase Revenue by Region
2.3.1 Global Urokinase Revenue by Region (2019-2024)
2.3.2 Global Urokinase Revenue by Region (2025-2030)
2.4 Global Urokinase Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Urokinase Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Urokinase Sales Quantity by Region
2.6.1 Global Urokinase Sales Quantity by Region (2019-2024)
2.6.2 Global Urokinase Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Urokinase Sales Quantity by Manufacturers
3.1.1 Global Urokinase Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Urokinase Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Urokinase Sales in 2023
3.2 Global Urokinase Revenue by Manufacturers
3.2.1 Global Urokinase Revenue by Manufacturers (2019-2024)
3.2.2 Global Urokinase Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Urokinase Revenue in 2023
3.3 Global Urokinase Sales Price by Manufacturers
3.4 Global Key Players of Urokinase, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Urokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Urokinase, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Urokinase, Product Offered and Application
3.8 Global Key Manufacturers of Urokinase, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Urokinase Sales Quantity by Type
4.1.1 Global Urokinase Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Urokinase Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Urokinase Sales Quantity Market Share by Type (2019-2030)
4.2 Global Urokinase Revenue by Type
4.2.1 Global Urokinase Historical Revenue by Type (2019-2024)
4.2.2 Global Urokinase Forecasted Revenue by Type (2025-2030)
4.2.3 Global Urokinase Revenue Market Share by Type (2019-2030)
4.3 Global Urokinase Price by Type
4.3.1 Global Urokinase Price by Type (2019-2024)
4.3.2 Global Urokinase Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Urokinase Sales Quantity by Application
5.1.1 Global Urokinase Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Urokinase Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Urokinase Sales Quantity Market Share by Application (2019-2030)
5.2 Global Urokinase Revenue by Application
5.2.1 Global Urokinase Historical Revenue by Application (2019-2024)
5.2.2 Global Urokinase Forecasted Revenue by Application (2025-2030)
5.2.3 Global Urokinase Revenue Market Share by Application (2019-2030)
5.3 Global Urokinase Price by Application
5.3.1 Global Urokinase Price by Application (2019-2024)
5.3.2 Global Urokinase Price Forecast by Application (2025-2030)
6 North America
6.1 North America Urokinase Sales by Company
6.1.1 North America Urokinase Revenue by Company (2019-2024)
6.1.2 North America Urokinase Sales Quantity by Company (2019-2024)
6.2 North America Urokinase Market Size by Type
6.2.1 North America Urokinase Sales Quantity by Type (2019-2030)
6.2.2 North America Urokinase Revenue by Type (2019-2030)
6.3 North America Urokinase Market Size by Application
6.3.1 North America Urokinase Sales Quantity by Application (2019-2030)
6.3.2 North America Urokinase Revenue by Application (2019-2030)
6.4 North America Urokinase Market Size by Country
6.4.1 North America Urokinase Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Urokinase Revenue by Country (2019-2030)
6.4.3 North America Urokinase Sales Quantity by Country (2019-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Urokinase Sales by Company
7.1.1 Europe Urokinase Sales Quantity by Company (2019-2024)
7.1.2 Europe Urokinase Revenue by Company (2019-2024)
7.2 Europe Urokinase Market Size by Type
7.2.1 Europe Urokinase Sales Quantity by Type (2019-2030)
7.2.2 Europe Urokinase Revenue by Type (2019-2030)
7.3 Europe Urokinase Market Size by Application
7.3.1 Europe Urokinase Sales Quantity by Application (2019-2030)
7.3.2 Europe Urokinase Revenue by Application (2019-2030)
7.4 Europe Urokinase Market Size by Country
7.4.1 Europe Urokinase Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Urokinase Revenue by Country (2019-2030)
7.4.3 Europe Urokinase Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Urokinase Sales by Company
8.1.1 China Urokinase Sales Quantity by Company (2019-2024)
8.1.2 China Urokinase Revenue by Company (2019-2024)
8.2 China Urokinase Market Size by Type
8.2.1 China Urokinase Sales Quantity by Type (2019-2030)
8.2.2 China Urokinase Revenue by Type (2019-2030)
8.3 China Urokinase Market Size by Application
8.3.1 China Urokinase Sales Quantity by Application (2019-2030)
8.3.2 China Urokinase Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Urokinase Sales by Company
9.1.1 APAC Urokinase Sales Quantity by Company (2019-2024)
9.1.2 APAC Urokinase Revenue by Company (2019-2024)
9.2 APAC Urokinase Market Size by Type
9.2.1 APAC Urokinase Sales Quantity by Type (2019-2030)
9.2.2 APAC Urokinase Revenue by Type (2019-2030)
9.3 APAC Urokinase Market Size by Application
9.3.1 APAC Urokinase Sales Quantity by Application (2019-2030)
9.3.2 APAC Urokinase Revenue by Application (2019-2030)
9.4 APAC Urokinase Market Size by Region
9.4.1 APAC Urokinase Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Urokinase Revenue by Region (2019-2030)
9.4.3 APAC Urokinase Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Urokinase Sales by Company
10.1.1 Middle East, Africa and Latin America Urokinase Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Urokinase Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Urokinase Market Size by Type
10.2.1 Middle East, Africa and Latin America Urokinase Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Urokinase Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Urokinase Market Size by Application
10.3.1 Middle East, Africa and Latin America Urokinase Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Urokinase Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Urokinase Market Size by Country
10.4.1 Middle East, Africa and Latin America Urokinase Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Urokinase Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Urokinase Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Syner-Med
11.1.1 Syner-Med Company Information
11.1.2 Syner-Med Overview
11.1.3 Syner-Med Urokinase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Syner-Med Urokinase Products and Services
11.1.5 Syner-Med Urokinase SWOT Analysis
11.1.6 Syner-Med Recent Developments
11.2 Wanhua Biochem
11.2.1 Wanhua Biochem Company Information
11.2.2 Wanhua Biochem Overview
11.2.3 Wanhua Biochem Urokinase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 Wanhua Biochem Urokinase Products and Services
11.2.5 Wanhua Biochem Urokinase SWOT Analysis
11.2.6 Wanhua Biochem Recent Developments
11.3 Jiangxi Haoran Bio-Pharma
11.3.1 Jiangxi Haoran Bio-Pharma Company Information
11.3.2 Jiangxi Haoran Bio-Pharma Overview
11.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Jiangxi Haoran Bio-Pharma Urokinase Products and Services
11.3.5 Jiangxi Haoran Bio-Pharma Urokinase SWOT Analysis
11.3.6 Jiangxi Haoran Bio-Pharma Recent Developments
11.4 Jiangsu Aidea Pharmaceutical
11.4.1 Jiangsu Aidea Pharmaceutical Company Information
11.4.2 Jiangsu Aidea Pharmaceutical Overview
11.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 Jiangsu Aidea Pharmaceutical Urokinase Products and Services
11.4.5 Jiangsu Aidea Pharmaceutical Urokinase SWOT Analysis
11.4.6 Jiangsu Aidea Pharmaceutical Recent Developments
11.5 Techpool
11.5.1 Techpool Company Information
11.5.2 Techpool Overview
11.5.3 Techpool Urokinase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 Techpool Urokinase Products and Services
11.5.5 Techpool Urokinase SWOT Analysis
11.5.6 Techpool Recent Developments
11.6 Microbic Biosystems
11.6.1 Microbic Biosystems Company Information
11.6.2 Microbic Biosystems Overview
11.6.3 Microbic Biosystems Urokinase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Microbic Biosystems Urokinase Products and Services
11.6.5 Microbic Biosystems Urokinase SWOT Analysis
11.6.6 Microbic Biosystems Recent Developments
11.7 LIVZON
11.7.1 LIVZON Company Information
11.7.2 LIVZON Overview
11.7.3 LIVZON Urokinase Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 LIVZON Urokinase Products and Services
11.7.5 LIVZON Urokinase SWOT Analysis
11.7.6 LIVZON Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Urokinase Value Chain Analysis
12.2 Urokinase Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Urokinase Production Mode & Process
12.4 Urokinase Sales and Marketing
12.4.1 Urokinase Sales Channels
12.4.2 Urokinase Distributors
12.5 Urokinase Customers
13 Market Dynamics
13.1 Urokinase Industry Trends
13.2 Urokinase Market Drivers
13.3 Urokinase Market Challenges
13.4 Urokinase Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Urokinase Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Urokinase Powder
Table 3. Major Manufacturers of Urokinase Solution
Table 4. Global Urokinase Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Urokinase Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Urokinase Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Urokinase Revenue Market Share by Region (2019-2024)
Table 8. Global Urokinase Revenue by Region (2025-2030) & (US$ Million)
Table 9. Global Urokinase Revenue Market Share by Region (2025-2030)
Table 10. Global Urokinase Sales Quantity by Region: 2019 VS 2023 VS 2030 (BIU)
Table 11. Global Urokinase Sales by Region (2019-2024) & (BIU)
Table 12. Global Urokinase Sales Market Share by Region (2019-2024)
Table 13. Global Urokinase Sales by Region (2025-2030) & (BIU)
Table 14. Global Urokinase Sales Market Share by Region (2025-2030)
Table 15. Global Urokinase Sales Quantity by Manufacturers (2019-2024) & (BIU)
Table 16. Global Urokinase Sales Quantity Share by Manufacturers (2019-2024)
Table 17. Global Urokinase Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Urokinase Revenue Share by Manufacturers (2019-2024)
Table 19. Global Urokinase Price by Manufacturers 2019-2024 (US$/MIU)
Table 20. Global Key Players of Urokinase, Industry Ranking, 2022 VS 2023
Table 21. Global Urokinase Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Urokinase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urokinase as of 2023)
Table 23. Global Key Manufacturers of Urokinase, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Urokinase, Product Offered and Application
Table 25. Global Key Manufacturers of Urokinase, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Urokinase Sales Quantity by Type (2019-2024) & (BIU)
Table 28. Global Urokinase Sales Quantity by Type (2025-2030) & (BIU)
Table 29. Global Urokinase Sales Quantity Share by Type (2019-2024)
Table 30. Global Urokinase Sales Quantity Share by Type (2025-2030)
Table 31. Global Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Urokinase Revenue Share by Type (2019-2024)
Table 34. Global Urokinase Revenue Share by Type (2025-2030)
Table 35. Urokinase Price by Type (2019-2024) & (US$/MIU)
Table 36. Global Urokinase Price Forecast by Type (2025-2030) & (US$/MIU)
Table 37. Global Urokinase Sales Quantity by Application (2019-2024) & (BIU)
Table 38. Global Urokinase Sales Quantity by Application (2025-2030) & (BIU)
Table 39. Global Urokinase Sales Quantity Share by Application (2019-2024)
Table 40. Global Urokinase Sales Quantity Share by Application (2025-2030)
Table 41. Global Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Urokinase Revenue Share by Application (2019-2024)
Table 44. Global Urokinase Revenue Share by Application (2025-2030)
Table 45. Urokinase Price by Application (2019-2024) & (US$/MIU)
Table 46. Global Urokinase Price Forecast by Application (2025-2030) & (US$/MIU)
Table 47. North America Urokinase Revenue by Company (2019-2024) & (US$ Million)
Table 48. North America Urokinase Sales Quantity by Company (2019-2024) & (BIU)
Table 49. North America Urokinase Sales Quantity by Type (2019-2024) & (BIU)
Table 50. North America Urokinase Sales Quantity by Type (2025-2030) & (BIU)
Table 51. North America Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 52. North America Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 53. North America Urokinase Sales Quantity by Application (2019-2024) & (BIU)
Table 54. North America Urokinase Sales Quantity by Application (2025-2030) & (BIU)
Table 55. North America Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 56. North America Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 57. North America Urokinase Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 58. North America Urokinase Revenue by Country (2019-2024) & (US$ Million)
Table 59. North America Urokinase Revenue by Country (2025-2030) & (US$ Million)
Table 60. North America Urokinase Sales Quantity by Country (2019-2024) & (BIU)
Table 61. North America Urokinase Sales Quantity by Country (2025-2030) & (BIU)
Table 62. Europe Urokinase Sales Quantity by Company (2019-2024) & (BIU)
Table 63. Europe Urokinase Revenue by Company (2019-2024) & (US$ Million)
Table 64. Europe Urokinase Sales Quantity by Type (2019-2024) & (BIU)
Table 65. Europe Urokinase Sales Quantity by Type (2025-2030) & (BIU)
Table 66. Europe Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 67. Europe Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 68. Europe Urokinase Sales Quantity by Application (2019-2024) & (BIU)
Table 69. Europe Urokinase Sales Quantity by Application (2025-2030) & (BIU)
Table 70. Europe Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 71. Europe Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 72. Europe Urokinase Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 73. Europe Urokinase Revenue by Country (2019-2024) & (US$ Million)
Table 74. Europe Urokinase Revenue by Country (2025-2030) & (US$ Million)
Table 75. Europe Urokinase Sales Quantity by Country (2019-2024) & (BIU)
Table 76. Europe Urokinase Sales Quantity by Country (2025-2030) & (BIU)
Table 77. China Urokinase Sales Quantity by Company (2019-2024) & (BIU)
Table 78. China Urokinase Revenue by Company (2019-2024) & (US$ Million)
Table 79. China Urokinase Sales Quantity by Type (2019-2024) & (BIU)
Table 80. China Urokinase Sales Quantity by Type (2025-2030) & (BIU)
Table 81. China Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 82. China Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 83. China Urokinase Sales Quantity by Application (2019-2024) & (BIU)
Table 84. China Urokinase Sales Quantity by Application (2025-2030) & (BIU)
Table 85. China Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 86. China Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 87. APAC Urokinase Sales Quantity by Company (2019-2024) & (BIU)
Table 88. APAC Urokinase Revenue by Company (2019-2024) & (US$ Million)
Table 89. APAC Urokinase Sales Quantity by Type (2019-2024) & (BIU)
Table 90. APAC Urokinase Sales Quantity by Type (2025-2030) & (BIU)
Table 91. APAC Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 92. APAC Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 93. APAC Urokinase Sales Quantity by Application (2019-2024) & (BIU)
Table 94. APAC Urokinase Sales Quantity by Application (2025-2030) & (BIU)
Table 95. APAC Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 96. APAC Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 97. APAC Urokinase Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 98. APAC Urokinase Revenue by Region (2019-2024) & (US$ Million)
Table 99. APAC Urokinase Revenue by Region (2025-2030) & (US$ Million)
Table 100. APAC Urokinase Sales Quantity by Region (2019-2024) & (BIU)
Table 101. APAC Urokinase Sales Quantity by Region (2025-2030) & (BIU)
Table 102. Middle East, Africa and Latin America Urokinase Sales Quantity by Company (2019-2024) & (BIU)
Table 103. Middle East, Africa and Latin America Urokinase Revenue by Company (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Urokinase Sales Quantity by Type (2019-2024) & (BIU)
Table 105. Middle East, Africa and Latin America Urokinase Sales Quantity by Type (2025-2030) & (BIU)
Table 106. Middle East, Africa and Latin America Urokinase Revenue by Type (2019-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Urokinase Revenue by Type (2025-2030) & (US$ Million)
Table 108. Middle East, Africa and Latin America Urokinase Sales Quantity by Application (2019-2024) & (BIU)
Table 109. Middle East, Africa and Latin America Urokinase Sales Quantity by Application (2025-2030) & (BIU)
Table 110. Middle East, Africa and Latin America Urokinase Revenue by Application (2019-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Urokinase Revenue by Application (2025-2030) & (US$ Million)
Table 112. Middle East, Africa and Latin America Urokinase Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 113. Middle East, Africa and Latin America Urokinase Revenue by Country (2019-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Urokinase Revenue by Country (2025-2030) & (US$ Million)
Table 115. Middle East, Africa and Latin America Urokinase Sales Quantity by Country (2019-2024) & (BIU)
Table 116. Middle East, Africa and Latin America Urokinase Sales Quantity by Country (2025-2030) & (BIU)
Table 117. Syner-Med Company Information
Table 118. Syner-Med Description and Overview
Table 119. Syner-Med Urokinase Sales Quantity (BIU), Revenue (US$ Million), Average Selling Price (ASP) (US$/MIU) and Gross Margin (2019-2024)
Table 120. Syner-Med Urokinase Product and Services
Table 121. Syner-Med Urokinase SWOT Analysis
Table 122. Syner-Med Recent Developments
Table 123. Wanhua Biochem Company Information
Table 124. Wanhua Biochem Description and Overview
Table 125. Wanhua Biochem Urokinase Sales Quantity (BIU), Revenue (US$ Million), Average Selling Price (ASP) (US$/MIU) and Gross Margin (2019-2024)
Table 126. Wanhua Biochem Urokinase Product and Services
Table 127. Wanhua Biochem Urokinase SWOT Analysis
Table 128. Wanhua Biochem Recent Developments
Table 129. Jiangxi Haoran Bio-Pharma Company Information
Table 130. Jiangxi Haoran Bio-Pharma Description and Overview
Table 131. Jiangxi Haoran Bio-Pharma Urokinase Sales Quantity (BIU), Revenue (US$ Million), Average Selling Price (ASP) (US$/MIU) and Gross Margin (2019-2024)
Table 132. Jiangxi Haoran Bio-Pharma Urokinase Product and Services
Table 133. Jiangxi Haoran Bio-Pharma Urokinase SWOT Analysis
Table 134. Jiangxi Haoran Bio-Pharma Recent Developments
Table 135. Jiangsu Aidea Pharmaceutical Company Information
Table 136. Jiangsu Aidea Pharmaceutical Description and Overview
Table 137. Jiangsu Aidea Pharmaceutical Urokinase Sales Quantity (BIU), Revenue (US$ Million), Average Selling Price (ASP) (US$/MIU) and Gross Margin (2019-2024)
Table 138. Jiangsu Aidea Pharmaceutical Urokinase Product and Services
Table 139. Jiangsu Aidea Pharmaceutical Urokinase SWOT Analysis
Table 140. Jiangsu Aidea Pharmaceutical Recent Developments
Table 141. Techpool Company Information
Table 142. Techpool Description and Overview
Table 143. Techpool Urokinase Sales Quantity (BIU), Revenue (US$ Million), Average Selling Price (ASP) (US$/MIU) and Gross Margin (2019-2024)
Table 144. Techpool Urokinase Product and Services
Table 145. Techpool Urokinase SWOT Analysis
Table 146. Techpool Recent Developments
Table 147. Microbic Biosystems Company Information
Table 148. Microbic Biosystems Description and Overview
Table 149. Microbic Biosystems Urokinase Sales Quantity (BIU), Revenue (US$ Million), Average Selling Price (ASP) (US$/MIU) and Gross Margin (2019-2024)
Table 150. Microbic Biosystems Urokinase Product and Services
Table 151. Microbic Biosystems Urokinase SWOT Analysis
Table 152. Microbic Biosystems Recent Developments
Table 153. LIVZON Company Information
Table 154. LIVZON Description and Overview
Table 155. LIVZON Urokinase Sales Quantity (BIU), Revenue (US$ Million), Average Selling Price (ASP) (US$/MIU) and Gross Margin (2019-2024)
Table 156. LIVZON Urokinase Product and Services
Table 157. LIVZON Urokinase SWOT Analysis
Table 158. LIVZON Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Urokinase Distributors List
Table 162. Urokinase Customers List
Table 163. Urokinase Market Trends
Table 164. Urokinase Market Drivers
Table 165. Urokinase Market Challenges
Table 166. Urokinase Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Urokinase Product Picture
Figure 2. Global Urokinase Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Urokinase Market Share by Type in 2023 & 2030
Figure 4. Urokinase Powder Product Picture
Figure 5. Urokinase Solution Product Picture
Figure 6. Global Urokinase Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Urokinase Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Urokinase Report Years Considered
Figure 12. Global Urokinase Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Urokinase Revenue 2019-2030 (US$ Million)
Figure 14. Global Urokinase Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 15. Global Urokinase Sales Quantity 2019-2030 (BIU)
Figure 16. Global Urokinase Sales Quantity Market Share by Region (2019-2024)
Figure 17. Global Urokinase Sales Quantity Market Share by Region (2025-2030)
Figure 18. North America Urokinase Sales Quantity YoY (2019-2030) & (BIU)
Figure 19. North America Urokinase Revenue YoY (2019-2030) & (US$ Million)
Figure 20. Europe Urokinase Sales Quantity YoY (2019-2030) & (BIU)
Figure 21. Europe Urokinase Revenue YoY (2019-2030) & (US$ Million)
Figure 22. China Urokinase Sales Quantity YoY (2019-2030) & (BIU)
Figure 23. China Urokinase Revenue YoY (2019-2030) & (US$ Million)
Figure 24. APAC Urokinase Sales Quantity YoY (2019-2030) & (BIU)
Figure 25. APAC Urokinase Revenue YoY (2019-2030) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Urokinase Sales Quantity YoY (2019-2030) & (BIU)
Figure 27. Middle East, Africa and Latin America Urokinase Revenue YoY (2019-2030) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Urokinase Sales Quantity in 2023
Figure 29. The Top 10 and Top 5 Players Market Share by Urokinase Revenue in 2023
Figure 30. Urokinase Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 31. Global Urokinase Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Urokinase Revenue Market Share by Type (2019-2030)
Figure 33. Global Urokinase Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Urokinase Revenue Market Share by Application (2019-2030)
Figure 35. North America Urokinase Revenue Market Share by Company in 2023
Figure 36. North America Urokinase Sales Quantity Market Share by Company in 2023
Figure 37. North America Urokinase Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Urokinase Revenue Market Share by Type (2019-2030)
Figure 39. North America Urokinase Sales Quantity Market Share by Application (2019-2030)
Figure 40. North America Urokinase Revenue Market Share by Application (2019-2030)
Figure 41. North America Urokinase Revenue Share by Country (2019-2030)
Figure 42. North America Urokinase Sales Quantity Share by Country (2019-2030)
Figure 43. United States Urokinase Revenue (2019-2030) & (US$ Million)
Figure 44. Canada Urokinase Revenue (2019-2030) & (US$ Million)
Figure 45. Europe Urokinase Sales Quantity Market Share by Company in 2023
Figure 46. Europe Urokinase Revenue Market Share by Company in 2023
Figure 47. Europe Urokinase Sales Quantity Market Share by Type (2019-2030)
Figure 48. Europe Urokinase Revenue Market Share by Type (2019-2030)
Figure 49. Europe Urokinase Sales Quantity Market Share by Application (2019-2030)
Figure 50. Europe Urokinase Revenue Market Share by Application (2019-2030)
Figure 51. Europe Urokinase Revenue Share by Country (2019-2030)
Figure 52. Europe Urokinase Sales Quantity Share by Country (2019-2030)
Figure 53. Germany Urokinase Revenue (2019-2030) & (US$ Million)
Figure 54. France Urokinase Revenue (2019-2030) & (US$ Million)
Figure 55. U.K. Urokinase Revenue (2019-2030) & (US$ Million)
Figure 56. Italy Urokinase Revenue (2019-2030) & (US$ Million)
Figure 57. Russia Urokinase Revenue (2019-2030) & (US$ Million)
Figure 58. China Urokinase Sales Quantity Market Share by Company in 2023
Figure 59. China Urokinase Revenue Market Share by Company in 2023
Figure 60. China Urokinase Sales Quantity Market Share by Type (2019-2030)
Figure 61. China Urokinase Revenue Market Share by Type (2019-2030)
Figure 62. China Urokinase Sales Quantity Market Share by Application (2019-2030)
Figure 63. China Urokinase Revenue Market Share by Application (2019-2030)
Figure 64. APAC Urokinase Sales Quantity Market Share by Company in 2023
Figure 65. APAC Urokinase Revenue Market Share by Company in 2023
Figure 66. APAC Urokinase Sales Quantity Market Share by Type (2019-2030)
Figure 67. APAC Urokinase Revenue Market Share by Type (2019-2030)
Figure 68. APAC Urokinase Sales Quantity Market Share by Application (2019-2030)
Figure 69. APAC Urokinase Revenue Market Share by Application (2019-2030)
Figure 70. APAC Urokinase Revenue Share by Region (2019-2030)
Figure 71. APAC Urokinase Sales Quantity Share by Region (2019-2030)
Figure 72. Japan Urokinase Revenue (2019-2030) & (US$ Million)
Figure 73. South Korea Urokinase Revenue (2019-2030) & (US$ Million)
Figure 74. China Taiwan Urokinase Revenue (2019-2030) & (US$ Million)
Figure 75. Southeast Asia Urokinase Revenue (2019-2030) & (US$ Million)
Figure 76. India Urokinase Revenue (2019-2030) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Urokinase Sales Quantity Market Share by Company in 2023
Figure 78. Middle East, Africa and Latin America Urokinase Revenue Market Share by Company in 2023
Figure 79. Middle East, Africa and Latin America Urokinase Sales Quantity Market Share by Type (2019-2030)
Figure 80. Middle East, Africa and Latin America Urokinase Revenue Market Share by Type (2019-2030)
Figure 81. Middle East, Africa and Latin America Urokinase Sales Quantity Market Share by Application (2019-2030)
Figure 82. Middle East, Africa and Latin America Urokinase Revenue Market Share by Application (2019-2030)
Figure 83. Middle East, Africa and Latin America Urokinase Sales Quantity Share by Country (2019-2030)
Figure 84. Middle East, Africa and Latin America Urokinase Revenue Share by Country (2019-2030)
Figure 85. Brazil Urokinase Revenue (2019-2030) & (US$ Million)
Figure 86. Mexico Urokinase Revenue (2019-2030) & (US$ Million)
Figure 87. Turkey Urokinase Revenue (2019-2030) & (US$ Million)
Figure 88. Israel Urokinase Revenue (2019-2030) & (US$ Million)
Figure 89. GCC Countries Urokinase Revenue (2019-2030) & (US$ Million)
Figure 90. Urokinase Value Chain
Figure 91. Urokinase Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Urokinase market size from 2024 to 2030?
The annual compound growth rate of the global Urokinase market is 5.2% 2024 to 2030.
What was the global market size of Urokinase in 2030?
What was the global market size of Urokinase in 2024?
Which companies rank high in the global Urokinase market?
Which region is expected to have the highest market share?
Related Reports
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 77
USD 4250.00
(Single User License)
Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 116
USD 2900.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 3950.00
(Single User License)
Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 147
USD 4900.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 121
USD 5900.00
(Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 79
USD 4250.00
(Single User License)
Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published Date: 2025-01-16
Pages: 79
USD 2900.00
(Single User License)
Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published Date: 2024-04-07
Pages: 89
USD 4900.00
(Single User License)
Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Urokinase market size was US$ 82.09 million in 2025 and is forecast to reach a readjusted size of US$ 120 million by 2032 with a CAGR of 5.2% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 77
USD 4250.00 (Single User License)Global Urokinase Market Research Report 2026
The global Urokinase market was valued at US$ 82.09 million in 2025 and is anticipated to reach US$ 120 million by 2032, at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 116
USD 2900.00 (Single User License)Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Urokinase was estimated to be worth US$ 82.09 million in 2025 and is projected to reach US$ 120 million, growing at a CAGR of 5.2% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 3950.00 (Single User License)Global Urokinase Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Urokinase market is projected to grow from US$ 49.8 million in 2024 to US$ 70.6 million by 2031, at a CAGR of 5.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 147
USD 4900.00 (Single User License)Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Urokinase was estimated to be worth US$ 49.8 million and is forecast to reach approximately US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 121
USD 5900.00 (Single User License)Global Urokinase Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Urokinase market size was US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 79
USD 4250.00 (Single User License)Urokinase- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Urokinase was estimated to be worth US$ 49.8 million in 2024 and is forecast to a readjusted size of US$ 70.6 million by 2031 with a CAGR of 5.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)Global Urokinase Market Research Report 2025
The global market for Urokinase was valued at US$ 49.8 million in the year 2024 and is projected to reach a revised size of US$ 70.6 million by 2031, growing at a CAGR of 5.2% during the forecast period.
Published: 2025-01-16
Pages: 79
USD 2900.00 (Single User License)Global Urokinase Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)Global Urokinase Market Insights, Forecast to 2030
Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Published: 2024-04-07
Pages: 89
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5600.00
USD 8400.00
USD 11200.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now